AZTRAzitra Inc

0.1328USD+6.07%Mkt Cap: 2.15M $P/E: 6.64

Azitra, Inc., an early-stage clinical biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and topical live biotherapeutic products to treat skin diseases in the United States…

Key Statistics

Company
Market Cap2.15M $
Enterprise Value1.73M $
Revenue (TTM)
Gross Profit
Net Income (TTM)-10.96M $
Revenue/Share
Last Price0.1328 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees13
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN
Valuation
P/E (Trailing)6.64
P/E (Forward)-0.26
PEG
EV/EBITDA-0.14
EV/Revenue
P/S
P/B1.10
EPS (TTM)0.02
EPS (Forward)-0.52
52W Range
0.10003% of range1.400
52W High1.400 USD
52W Low0.1000 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-288.21%
ROA-218.00%
Growth
Revenue Growth
Earnings Growth
Cash Flow & Leverage
Operating CF-11.22M $
CapEx (TTM)186.06K $
FCF Margin
FCF Yield-336.78%
Net Debt-6.32M $
Net Debt/EBITDA0.52
Balance Sheet
Debt/Equity0.11
Current Ratio4.86
Quick Ratio4.49
Book Value/Sh0.1210 USD
Cash/Share0.1110 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split15:100
Split DateAug 21, 2025
Analyst Consensus
Rating
Target (Mean)0.7750 USD
Upside (mean)+483.6%
Target Range0.5500 USD1.000 USD
$0.5500+483.6% to mean$1.000
# Analysts2
Ownership
Shares Out.60.60M
Float51.25M
Insiders7.59%
Institutions32.04%
Short Interest
Short Ratio0.1d
Short % Float1.46%
Short % Out.0.96%
Shares Short154.67K
Short (prev mo.)278.21K
Technical
SMA 500.1516 (-12.4%)
SMA 2000.2313 (-42.6%)
Beta-1.18
S&P 52W Chg19.18%
Avg Vol (30d)1.51M
Avg Vol (10d)1.12M
Technical Indicators
RSI (14)44.4
MACD-0.0051
MACD Signal-0.0065
MACD Hist.+0.0014
BB Upper0.1441 USD
BB Middle0.1336 USD
BB Lower0.1232 USD
BB Width15.61%
ATR (14)0.0115 USD
Vol Ratio (20d)1.46x